Douglas A. Arenberg

Papers

1

Total Citations

8

H-Index

1

About

Douglas A. Arenberg is a leading pulmonologist and researcher whose work centers on the early detection and diagnosis of lung cancer, with a particular focus on improving bronchoscopic techniques. His major contributions include advancing the use of navigational bronchoscopy and rapid on-site evaluation (ROSE) to enhance diagnostic accuracy for peripheral pulmonary lesions. Through his involvement in the landmark, prospective NAVIGATE study, Arenberg demonstrated how biopsy tool selection and real-time cytological assessment can significantly impact the yield for malignant lesions, a finding that has shaped current clinical practice. With over 8 citations for this pivotal work, his research has helped reduce unnecessary invasive procedures and improve patient outcomes. Arenberg’s notable achievements include his role as a key opinion leader in interventional pulmonology, where he has authored numerous guidelines and mentored a generation of physicians. His work remains essential reading for clinicians and researchers striving to refine lung cancer diagnostics and reduce the burden of this deadly disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
THE IMPACT OF BIOPSY TOOL CHOICE AND RAPID ON-SITE EVALUATION ON THE DIAGNOSTIC ACCURACY FOR MALIGNANT LESIONS IN THE PROSPECTIVE, MULTICENTER NAVIGATE STUDY
8 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago